期刊文献+

Cyclin D1和P16在增生性瘢痕成纤维细胞中的表达及意义 被引量:1

Expression and significance of Cyclin D1 and P16 in fibroblasts of hypertrophic scars
下载PDF
导出
摘要 目的观察增生性瘢痕中成纤维细胞中Cyclin D1、P16的表达,探讨其与正常皮肤组织之间的差异关联性。方法12例增生性瘢痕为实验组,正常皮肤组织作为对照组,进行成纤维细胞培养,通过SABC免疫组化检测两组中CyclinD1、P16的表达。结果 Cyclin D1在对照组成纤维细胞表达为阴性,实验组的阳性表达率为83.3%,两者比较差异具有统计学意义(P<0.01);与对照组P16阴性比较,增生性瘢痕成纤维细胞的P16阳性表达率为75.0%,差异具有统计学意义(P<0.01)。结论 Cyclin D1和P16作为一对细胞周期的正负调控因子的表达失衡是增生性瘢痕的发展的重要机制。 Objective To observe the Cyclin D1, P16 expression in hypertrophic scar fibroblasts, and to explore the differ- ences between normal skin tissue correlation. Methods All of 12 cases of hypertrophic scars for the experimental group, normal skin tissue as a control group, the two groups of Cyclin D1 and P16 expression were detected by SABC immunohis- tochemical. Results Cyclin D1 of fibroblasts in the control expression of negative, positive expression rate was 83.3% of the experimental group, there was a statistically significant difference(P 〈 0.01 );compared with the control group PI6 negative P16 positive expression of hypertrophic scar fibroblasts rate of 75.0%, there was a significant difference (P 〈 0.01 ). Con- clusion Cyclin D1 and P16 cell cycle as a pair of positive and negative regulatory factor expression imbalance is an im- portant mechanism of the development of hypertrophic scars.
出处 《中国现代医生》 2012年第35期7-8,共2页 China Modern Doctor
基金 黑龙江省教育厅科学技术研究项目(11551548)
关键词 CYCLIND1 P16 增生性瘢痕 成纤维细胞 Cyclin D1 P16 Hypertrophic scar Fibroblasts
  • 相关文献

参考文献2

二级参考文献15

  • 1Sauter ER,Takemoto R,Litwin S.et al.p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma[J].Cancer Gene Ther,2002,9(10): 807.
  • 2Poolman RA,Brooks G.Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy[J].J Mol Cell Cardiol,1998,30(10): 2121.
  • 3Myles ME,Russell JD,Trupin JS,et al.Keloid fibroblasts are refractory to inhibiton of DNA synthesis by phorbol esters.J Biol Chem,1992,267:9014-9020.
  • 4Mishima K,Otani H,Tanabe T,et al.Molecular mechanisms for alpha2-adrenoceptor-mediated regulation of synoviocyte populations.Jpn J Pharmacol,2001,85:214-226.
  • 5SambrookJ FritschEF ManiatisT 金冬雁 黎孟枫 译 侯云德 校.分子克隆实验指南(第2版)[M].北京:科学出版社,2002.870-898,556-558.
  • 6Gauldie J,Sime PJ,Xing Z,et al.Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis.Curr Top Pathol,1999,93:35-45.
  • 7Razzaque MS,Koji T,Harada T,et,al.Localization in situ of typeⅥ collagen protein and its mRNA in mesangial proliferative glomerulonephritis using renal biopsy sections.Histochem Cell Biol,1999,111:1-6.
  • 8Razzaque MS,Taguchi T.Cellular and molecular events leading to renal tubulointerstitial fibrosis.Med Electron Microsc,2002,35:68-80.
  • 9Saito T,Tazawa K,Yokoyama Y,et al.Surgical stress inhibits the growth of fibroblasts through the elevation of plasma catecholamine and cortisol concentrations.Surg Today,1997,27:627-631.
  • 10Zhang H,Facemire CS,Banes AJ,et al.Different alpha-adrenoceptors mediate migration of vascular smooth muscle cells and adventitial fibroblasts in vitro.Am J Physiol Heart Circ Physiol,2002,282:2364-2370.

共引文献16

同被引文献18

  • 1Joseph JD, Yeh ES, Swenson KI, et al. The peptidyl-prolyl isomerase Pinl [J]. Prog Cell Cycle Res,2003,5:477-487.
  • 2Lu KP, Liou YC,Zhou XZ. Pinning down the proline-direct- ed phosphorylation signaling [J]. Trends Cell Biol,2002,12 (4) : 164-172.
  • 3Lu KP. Pinning down cell signaling,cancer and Alzheimer's disease [J]. Trends Biochem Sci ,2004,29(4):200-209.
  • 4Zhou XZ, Kops O,Wemer A,et al. Pinl-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins [J]. Mol Cell, 2000,6 (4) : 873-883.
  • 5Ryo A,Liou YC,Wulf G,et al. Pinl is an E2F target gene essential for the Neu/Ras-induced transformation of mam- mary epithelial cells [J]. Mol Cell Biol,2002,22(15):5281- 5205.
  • 6Bao L, Kimzey A, Sauter G, et al. Prevalent overexpression of prolyl isomerase Pinl in human cancers [J]. Am J Pathol, 2004,164(5) : 1727-1737.
  • 7Lu KP,Suizu F,Zhou XZ,et al. Targeting carcinogenesis: a role for the prolyl isomerase Pinl [J]. Mol Carcinog,2006,45 (6) :397-402.
  • 8Tatara Y, Lin YC, Bamba Y, et al. Dipentamethylene thi- uram monosulfide is a novel inhibitor of Pinl [J]. Bioehem Biophys Res Commun, 2009,384 (3) : 394-398.
  • 9Liu T,Liu Y,Kao HY,et al. Membrane permeable cyclic pep- tidyl inhibitors against human peptidylprolyl isomerase Pinl [J]. J Med Chem,2010,53(6) :2494-2501.
  • 10Zhang Y,Daum S,Wildemann D,et al. Structural basis for high-affinity peptide inhibition of human Pinl [J]. ACS Chem Biol, 2007,2 (5) : 320-328.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部